Skip to content
Clinical Trials – home
Azienda Unita' Sanitaria Locale Toscana Sud Est
Sponsor

Azienda Unita' Sanitaria Locale Toscana Sud Est

Italy Via Senese 169, 58100 Grosseto, Italy

About the sponsor

Clinical research includes management of cardiogenic shock, with attention to vasoactive and inotropic treatment strategies used in acute critical care. The sponsor’s interest centres on comparing approaches that influence tissue perfusion and lactate response in unstable cardiac patients.

  • Norepinephrine-based support
  • Dobutamine and combined inotropic therapy
  • Acute circulatory failure

This area reflects involvement in intensive management of severe cardiovascular instability and organ perfusion.

About Specializations

Azienda Unita' Sanitaria Locale Toscana Sud Est runs clinical trials in conditions such as Sedative therapy, Cardiogenic shock, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Sedative therapy

Not yet recruiting

Study on Sedation Safety and Effectiveness in Bronchoscopy: Comparing Propofol/Pethidine and Midazolam/Pethidine for Patients with Respiratory Conditions

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Propofol
  • Sponsor:Azienda Unita' Sanitaria Locale Toscana Sud Est

Cardiogenic shock

Not recruiting

Study Comparing Norepinephrine and Dobutamine for Patients with Cardiogenic Shock

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dobutamine
  • Sponsor:Azienda Unita' Sanitaria Locale Toscana Sud Est

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.